Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sheraton Philadelphia University City

Oct 22, 2018 1:45 PM - Oct 24, 2018 10:00 PM

3549 Chestnut Street, Philadelphia, PA 19104

Drug Safety and Pharmacovigilance Across the Product Lifecycle


In this comprehensive training course learn contemporary principles, regulatory expectations, and practical approaches to drug safety and pharmacovigilance in key regulatory jurisdictions, with a focus on the US and EU. The course curriculum is designed for the basic to intermediate level professional, and the topics will span the lifecycle of traditional innovative medicinal products, from first-in-human through the post-marketing phase. This blended learning course employs a mixture of pre-course online learning, informative instructional sessions, real-world case studies, and hands-on interactive exercises where learners can apply what they learn.

Couldn't attend this course?  Join us in Bethesda in April or Boston in August or Philadelphia in October

Related events you may be interested in:

What you will learn

  • Legal and regulatory basis for safety obligations, including a historical perspective
  • Principles, basic definitions, and pragmatic approaches for compliance
  • Basics of Individual Case Safety Reports (ICSRs) and periodic reports (DSUR, IND AR, PADER, PSUR/PBRER) in the pre-marketing, peri-approval, and post-marketing continuum  
  • Evaluation of seriousness, expectedness and causality
  • Data collection, processing, and requirements in the post-marketing phase, including MedDRA coding, safety query development, and evolving regulatory requirements
  • Overview of case processing and organization of a typical safety department
  • Safety audits and inspections
  • Introduction to signal detection
  • Introduction to benefit-risk assessment
  • Basics of risk management planning, EU Risk Management Plans, and Risk Evaluation and Mitigation Strategies (REMS)

Who should attend?

This program is designed for entry through intermediate level professionals involved in:

  • Drug safety/pharmacovigilance
  • Adverse event reporting
  • Case processing
  • Safety evaluation
  • Periodic safety reporting
  • Medical monitoring
  • Quality systems
  • Regulatory strategy, regulatory affairs
  • Risk management planning and development of formal Risk Management Plans and REMS
  • Disciplines that interact with or support safety and pharmacovigilance functions across the product lifecycle

Broadening their role within pre-market or post-market safety and pharmacovigilance functions

Learning objectives

At the conclusion of this activity, participants should be able to:

  • Identify the history, principles, and regulatory framework for clinical trials and post-marketing safety
  • Discuss the basic definitions of terms used in day-to-day pharmacovigilance work
  • Recognize basic international regulatory requirements for safety surveillance, as well as those requirements specific for the US and EU
  • Describe the criteria and elements of expedited and periodic reporting of drug safety information from first-in-human studies through the post-marketing phase
  • Demonstrate an awareness of risk management and signal detection principles

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.